Aurinia Pharmaceuticals Inc (STU:IKAP)
€ 9.252 -0.386 (-4%) Market Cap: 1.32 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 3.73 GF Score: 84/100

Aurinia Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 07, 2021 / 04:00PM GMT
Release Date Price: €10.51 (+1.84%)
Peter S. Greenleaf
Aurinia Pharmaceuticals Inc. - President, CEO & Director

Good morning, and welcome to the 2021 Aurinia Pharmaceuticals Inc. Annual General and Special Meeting. The meeting will now come to order. My name is Peter Greenleaf, and I'm the President and Chief Executive Officer of the corporation. Pursuant to the bylaws of the corporation, I will be acting as Chairman of the meeting today.

Due to the public health impact of COVID-19 pandemic and to support the health and well-being of our shareholders, employees, management and directors, this meeting will be our second time hosting a completely virtual meeting of shareholders.

In addition to tabling our financial statements, there are 8 motions that we will be voting on today. All of the motions will be voted on, we will announce our preliminary voting results, and the business of the meeting will officially come to close.

I will ask Stephen Robertson, Corporate Secretary of the corporation to act as Secretary for this meeting, and I will ask Kyle Gould of Computershare Investor Services Inc. to act as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot